Dr. Emadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
22 S Greene St
N9E24
Baltimore, MD 21201Phone+1 410-328-2596Fax+1 410-328-6896- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2007 - 2010
- University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2005 - 2007
- University of Kentucky College of MedicineInternship, Internal Medicine, 2004 - 2005
- Illinois Institute of TechnologyPhD, Organic Chemistry, 2000 - 2004
- Tehran University of Medical Sciences School of MedicineClass of 1999
Certifications & Licensure
- MD State Medical License 2006 - 2024
- WV State Medical License 2024 - 2024
- OH State Medical License 2005 - 2007
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2012 Jan 13
- 1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML) Start of enrollment: 2014 Apr 01
- Trial of Imatinib for Hospitalized Adults With COVID-19 Start of enrollment: 2020 Jun 02
- Join now to see all
Publications & Presentations
PubMed
- Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic Leukemia.Max An, Christine Dougherty, Yamini K Kathari, Ashkan Emadi> ;Pharmaceuticals. 2024 Mar 5
- Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease.Gabriela Sanchez-Petitto, Olga G Goloubeva, Jack Masur, James Childress, Tahreem Iqbal, Max An, Safwan Muhammad, Justin Lawson, Grace Li, Brian Barr, Ashkan Emadi, Jen...> ;Leukemia Research. 2024 Mar 1
- Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.Altman, J., Zuckerman, T., Koprivnikar, J., McCloskey, J., Kota, V., Keng, M., Frankfurt, O., Abaza, Y., Bixby, D., Emadi, A., Burch, M., Bhatnagar, B., Luger, S., Per...> ;Blood Advances. 2023 Dec 26
- Join now to see all
Press Mentions
- MacroGenics : Flotetuzumab (CD123 X CD3) as Salvage Therapy for PIF and ER AML (Aldoss)December 7th, 2020
- $50 Million Gift Will Spur Development of Morgantown Cancer CenterApril 7th, 2024
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
- University of Maryland Medical CenterBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: